Terheggen P M, Floot B G, Lempers E L, van Tellingen O, Begg A C, den Engelse L
Division of Chemical Carcinogenesis, Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam.
Cancer Chemother Pharmacol. 1991;28(3):185-91. doi: 10.1007/BF00685507.
Cytotoxic effects of cis-diamminedichloroplatinum-(II) (cis-DDP) are thought to be mediated by binding to DNA. Studies on binding of cis-DDP to cellular DNA rely heavily on the availability of specific antibodies. We therefore raised and characterized four rabbit antisera: one against cis-DDP-modified DNA (antiserum NKI-A59) and three others against the cis-DDP-modified (di)nucleotides cis-Pt(NH3)2d(pApG) (NKI-A68), cis-Pt(NH3)2d(GMP)2 (NKI-A10), and Pt(NH3)3dGMP (NKI-A39). Reactivities to platinum compounds were determined in an enzyme-linked immunosorbent assay (ELISA) and in a quantitative immunocytochemical assay. In the ELISA, NKI-A59 showed a high affinity for DNA heavily substituted with either cis-DDP or CBDCA [cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)]; amounts of platinum per well giving 50% inhibition (IA50) were as low as 15 and 76 fmol, respectively. NKI-A59 also showed affinity to cis-DDP-modified poly[d(G-C)].poly[d(G-C)], poly(dC), and poly(dG). No affinity was found for trans-DDP [trans-diamminedichloro-platinum(II)]-modified DNA, enzymatically digested cis-DDP-DNA, or cis-DDP-DNA, or cis-DDP-modified poly(dA).poly(dT), oligo(dA)15.oligo(dT)15, oligo(dG)21, oligo(dG)42, or oligo(dAAAG)10. The efficiency of binding to cis-DDP-DNA decreased with decreasing DNA modification levels. Although other cis-DDP-DNA- and cis-DDP-(di)nucleotide-specific antisera have been identified, NKI-A59 is the first antiserum described that is suitable for the in situ detection of cis-DDP-DNA adducts at clinically relevant platinum levels. Adduct-specific immunostaining signals in cultured RIF-1 cells or rat liver paralleled platinum-DNA binding as measured by atomic absorption spectroscopy. The antisera NKI-A68, NKI-A10, and NKI-A39 showed high affinity for their corresponding haptens and varying affinity for non-hapten cis-DDP-DNA adducts. Their affinity for digested cis-DDP-modified DNA was up to 30 times that for intact cis-DDP-DNA. Neither NKI-A68 nor NKI-A10 resulted in specific immunocytochemical staining of cis-DDP-DNA adducts. We conclude that NKI-A68, NKI-A10, and NKI-A39 are suitable for platinum-DNA adduct analysis of digested DNA in ELISA and that NKI-A59 is suitable for platinum-DNA adduct detection at the single-cell level using immunocytochemical methods.
顺二氯二氨铂(II)(顺铂)的细胞毒性作用被认为是通过与DNA结合来介导的。关于顺铂与细胞DNA结合的研究严重依赖于特异性抗体的可用性。因此,我们制备并鉴定了四种兔抗血清:一种针对顺铂修饰的DNA(抗血清NKI - A59),另外三种针对顺铂修饰的(二)核苷酸顺铂(NH3)2d(pApG)(NKI - A68)、顺铂(NH3)2d(GMP)2(NKI - A10)和铂(NH3)3dGMP(NKI - A39)。在酶联免疫吸附测定(ELISA)和定量免疫细胞化学测定中测定了对铂化合物的反应性。在ELISA中,NKI - A59对被顺铂或卡铂[顺二氨(1,1 - 环丁烷二羧酸)铂(II)]高度取代的DNA表现出高亲和力;每孔产生50%抑制(IA(50))的铂量分别低至15和76飞摩尔。NKI - A59对顺铂修饰的聚[d(G - C)]·聚[d(G - C)]、聚(dC)和聚(dG)也表现出亲和力。未发现对反式铂[反二氯二氨铂(II)]修饰的DNA、酶解的顺铂 - DNA或顺铂 - DNA、或顺铂修饰的聚(dA)·聚(dT)、寡聚(dA)({15})·寡聚(dT)({15})、寡聚(dG)({21})、寡聚(dG)({42})或寡聚(dAAAG)({10})有亲和力。与顺铂 - DNA加合物的结合效率随着DNA修饰水平的降低而降低。尽管已经鉴定出其他顺铂 - DNA和顺铂 - (二)核苷酸特异性抗血清,但NKI - A59是描述的第一种适用于在临床相关铂水平原位检测顺铂 - DNA加合物的抗血清。培养的RIF - 1细胞或大鼠肝脏中的加合物特异性免疫染色信号与通过原子吸收光谱法测量的铂 - DNA结合情况平行。抗血清NKI - A68、NKI - A10和NKI - A39对其相应的半抗原表现出高亲和力,对非半抗原顺铂 - DNA加合物表现出不同的亲和力。它们对酶解的顺铂修饰DNA的亲和力比对完整顺铂 - DNA的亲和力高30倍。NKI - A68和NKI - A10均未导致顺铂 - DNA加合物的特异性免疫细胞化学染色。我们得出结论,NKI - A68、NKI - A10和NKI - A39适用于ELISA中酶解DNA的铂 - DNA加合物分析,而NKI - A59适用于使用免疫细胞化学方法在单细胞水平检测铂 - DNA加合物。